Ascendis Pharma (Brazil) Buy Hold or Sell Recommendation
| A1SN34 Stock | BRL 48.42 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Ascendis Pharma AS is 'Not Rated'. Macroaxis provides Ascendis Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding A1SN34 positions. The advice algorithm takes into account all of Ascendis Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Ascendis Pharma's buy or sell advice are summarized below:
Real Value 0.0 | Hype Value 0.0 | Market Value 48.42 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ascendis Pharma AS given historical horizon and risk tolerance towards Ascendis Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Ascendis Pharma AS, the advice is generated through an automated system that utilizes algorithms and statistical models.
Ascendis |
Execute Ascendis Pharma Buy or Sell Advice
The Ascendis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ascendis Pharma AS. Macroaxis does not own or have any residual interests in Ascendis Pharma AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ascendis Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ascendis Pharma Trading Alerts and Improvement Suggestions
| Ascendis Pharma AS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M. | |
| Ascendis Pharma generates negative cash flow from operations |
Ascendis Pharma Returns Distribution Density
The distribution of Ascendis Pharma's historical returns is an attempt to chart the uncertainty of Ascendis Pharma's future price movements. The chart of the probability distribution of Ascendis Pharma daily returns describes the distribution of returns around its average expected value. We use Ascendis Pharma AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ascendis Pharma returns is essential to provide solid investment advice for Ascendis Pharma.
| Mean Return | 0.17 | Value At Risk | -2.7 | Potential Upside | 2.74 | Standard Deviation | 1.65 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ascendis Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ascendis Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ascendis Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ascendis Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ascendis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.21 | |
β | Beta against NYSE Composite | -0.54 | |
σ | Overall volatility | 1.66 | |
Ir | Information ratio | 0.05 |
Ascendis Pharma Volatility Alert
Ascendis Pharma AS currently demonstrates below-average downside deviation. It has Information Ratio of 0.05 and Jensen Alpha of 0.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ascendis Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ascendis Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ascendis Pharma Fundamentals Vs Peers
Comparing Ascendis Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ascendis Pharma's direct or indirect competition across all of the common fundamentals between Ascendis Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ascendis Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ascendis Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ascendis Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ascendis Pharma to competition |
| Fundamentals | Ascendis Pharma | Peer Average |
| Return On Equity | -0.67 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Operating Margin | (15.89) % | (5.51) % |
| Current Valuation | 34.82 B | 16.62 B |
| Shares Outstanding | 57.03 M | 571.82 M |
| Price To Book | 0.90 X | 9.51 X |
| Price To Sales | 1,080 X | 11.42 X |
| Revenue | 7.78 M | 9.43 B |
| Gross Profit | 4.25 M | 27.38 B |
| EBITDA | (364.64 M) | 3.9 B |
| Net Income | (383.58 M) | 570.98 M |
| Book Value Per Share | 8.08 X | 1.93 K |
| Cash Flow From Operations | (417.65 M) | 971.22 M |
| Number Of Employees | 639 | 18.84 K |
| Beta | 0.47 | -0.15 |
| Market Capitalization | 34.39 B | 19.03 B |
| Total Asset | 1.08 B | 29.47 B |
| Net Asset | 1.08 B |
Ascendis Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ascendis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ascendis Pharma Buy or Sell Advice
When is the right time to buy or sell Ascendis Pharma AS? Buying financial instruments such as Ascendis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ascendis Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ascendis Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Ascendis Pharma AS information on this page should be used as a complementary analysis to other Ascendis Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |